Gilead study finds HIV can evolve to resist lenacapavir, but doing so hampers the virus' replication
Now, Gilead has conducted an analysis of a phenomenon that can undermine all infectious disease therapies, including ...
Study Finds on MSN
Viral Protein Found In Cancer, Lupus, ALS Traced To Infection From Millions Of Years Ago
Researchers reveal structure of ancient viral protein appearing in breast cancer, lupus, and ALS, opening new paths for ...
LoveBScott on MSN
The digital frontline: How telehealth is winning the fight against HIV where traditional systems failed
Despite remarkable medical advances in HIV prevention over the past decade, significant gaps have persisted in the U.S.
Knowable Magazine reports 2025 faced turmoil in U.S. science amid job cuts and budget slashes, yet saw advances in gene ...
Future Pak becomes exclusive U.S. marketer for Mytesi® and Canalevia®-CA1 Meaningful non-dilutive capital enables Jaguar to ...
The Punch on MSN
How cycle of strikes left public hospitals helpless in 2025
From incessant health workers’ strikes and the deepening japa syndrome to US government funding cuts for HIV programmes and recurring disease outbreaks, Nigeria’s health sector in 2025 did not merely ...
Minaris, a global cell and gene therapy (CGT) contract development and manufacturing organization (CDMO) and multimodality ...
The National Agency for Food and Drug Administration and Control (NAFDAC) has warned Nigerians about the circulation ...
Up to additional $20M in milestone and other future payments Future Pak becomes exclusive U.S. marketer for Mytesi and Canalevia-CA1 Jaguar continues to be the manufacturer of Mytesi and Canalevia-CA1 ...
Human Immunodeficiency Virus (HIV) is a virus that attacks the body’s immune system, specifically the CD4 (T) cells, which ...
A Northwestern Medicine study published in Nature Communications has revealed how HIV can protect infected cells by altering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback